A new preprint links the company’s cell therapy to less brain inflammation in Alzheimer’s, just as it heads out on an ...

The whole-body scan company is launching a research network with 50+ institutions. Early findings come with some big open ...

The company added hormone therapy to its platform and released IBS results from nearly 16,000 members, with caveats attached.

All three Phase 3 trials of the weekly shot ribupatide have finished enrolling, and the head-to-head against semaglutide is ...

Patent cliffs and falling R&D productivity push the biggest players toward other people's science – our report puts numbers ...

Monte Rosa’s NEK7-targeting drug pulled several heart-risk biomarkers toward healthy levels in 108 people with obesity.

Reservoir offers the chance to preserve today’s immune cells for potential future therapies – but what might those cells eventually be worth? The youngest immune cells you will ever have may already ...

Diagnostic Imaging Centers of Texas will pair MRI and CT with VoxNeuro’s FDA-cleared EEG software for people recovering from injuries. Texas roads supply the scale for this story. In 2024, more than ...

A Lancet Neurology study of 130 blood proteins in patients receiving lecanemab suggests amyloid clearance and cognitive ...